BASiBroadcast

It’s always gratifying to hear how our clients and partners are using BASi products to conduct their studies and propel their research forward. Recently, Paul Moore, Director and Professor of Biological Studies at Bowling Green State University, wrote to us about his research using the tried and true BASi EC Epsilon electrochemical analyzer.

Since reengaging with BASi in 2017, I've seen positive trends that matter for 2018. We've had four consecutive quarters with positive earnings after a rough decade with both a slowly recovering economy and ongoing restructuring of the biopharma industry. Investing in growth is a priority. It is well recognized that life science innovation is very healthy, with new initiatives taking hold in editing out genetic abnormalities and marshaling the immune system to help root out a variety of cancers. The FDA approved many new therapies in 2017 and now promises to ease the way to more.